Pivalde, Hope you are well. Did you see today's article in Endpoints about the FDA's emphasizing amyloid degradation studies in clinical trials, etc?! About time! Hopefully, they are not biased about small cap companies or are not still pro BIG PHARMA, not to mention having executive decision makers that still have their hands deep in BP pockets. Actually, I think that the FDA has done some house cleaning and had some retirements during the last couple of years, thankfully. Best, B.H.
Ann: Notice Under Section 708A, page-25
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $18 | 4.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 51 | 66247657 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 31737802 | 13 |
View Market Depth
| Last trade - 10.55am 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.4¢ |
Change
-0.001 ( 11.1 %) |
||||
| Open | High | Low | Volume | ||
| 0.4¢ | 0.4¢ | 0.4¢ | 100000 | ||
| Last updated 11.49am 05/06/2024 ? | |||||
| ATH (ASX) Chart |